Behavioral Health Market Research Reports & Industry Analysis
Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders. Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behavior therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone.
The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.
Behavioral Health Industry Research & Market Reports
-
Neurostimulation Devices Market Size, Share & Trends Analysis Report by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence & Depression), By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator & Gastric Electric Stimulator), By Region, And Segment Forecasts, 2023 - 2032
... Stimulator & Gastric Electric Stimulator), By Region, And Segment Forecasts, 2023 - 2032 The global neurostimulation devices market size is expected to reach USD 14.74 billion by 2032, according to a new study by Polaris ... Read More
-
Anxiety and Panic Disorders Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major ... Read More
-
Anxiety Disorders & Depression Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type
... from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, ... Read More
-
The World Market for Massage, Psychological Aptitude-Testing, Artificial-Respiration, and Ozone, Oxygen or Aerosol Mechano-Therapy Apparatus: A 2024 Global Trade Perspective
... with the market for mechano-therapy appliances and apparatuses for massage, psychological aptitude-testing, ozone therapy, oxygen therapy, aerosol therapy, and artificial respiration. With the globalization of this market, managers can no longer be contented with a ... Read More
-
Mindfulness Meditation Application: Global Market
... global market for mindfulness meditation applications and analyzes market trends. Using 2022 as the base year, the report provides estimated market data for the forecast period of 2023 through 2028. The report also highlights major ... Read More
-
Global Psychedelic Drugs Market Size study & Forecast, by Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3 4-MethylEnedioxyMethamphetamine, Other Drug Types) by Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Other Applications), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Other Distribution Channels) and Regional Analysis, 2022-2029
... Disorder, Narcolepsy, Panic Disorders, Other Applications), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Other Distribution Channels) and Regional Analysis, 2022-2029 Global Psychedelic Drugs Market is valued approximately USD XX billion in 2021 and ... Read More
-
Global Sleep Disorders Treatment Market Size study & Forecast, by Drug Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, and Other Drug Types) by Application (Insomnia, Sleep Apnea, Narcolepsy, Circadian disorders, and Other Applications) and Regional Analysis, 2022-2029
... Sleep Disorders Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The sleep disorders treatment ... Read More
-
Global Neurotech Devices Market Size study & Forecast, by Product (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), by Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson’s Disease, Depression, Sleep Disorders, Essential Tremor), by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029
... by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029 Global Neurotech Devices Market is valued approximately USD 10.90 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Global Virtual Visits Market Size study & Forecast, by Service Type (Cold and Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioral Health) by Patient Group (Paediatric, Adults, Geriatric), and Regional Analysis, 2022-2029
... Global Virtual Visits Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Virtual visits are ... Read More
-
Global Pet Anxiety Vest Market Growth 2023-2029
... at a CAGR of 5.0% from 2023 to 2029. United States market for Pet Anxiety Vest is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Attention-deficit/hyperactivity disorder (ADHD) - Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Bipolar Disorder treatment Market, By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Bipolar disorder is a lifelong disease, which can be managed with proper medication. The medications used to manage bipolar disorder symptoms ... Read More
-
Psychedelic Drugs: Global Market Outlook
... competitive intelligence and regional trends. It also discusses market the competitive scenarios that will form the base data for qualitative analysis and market estimates. In this report, the global market for psychedelic drugs is segmented ... Read More
-
Global Mental Health Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Observational, Expanded Access) by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Government Agencies, Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029
... Others), by Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others) and Regional Analysis, 2022-2029 Global Mental Health Clinical Trials Market is valued at approximately USD XX billion in 2021 and ... Read More
-
Anxiety Disorders and Depression Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... The COVID-19 outbreak significantly impacted the growth due to the increased number of cases of anxiety and depression during the pandemic period. For instance, a WHO report published in March 2022 stated that in the ... Read More
-
U.S. Psychedelic Mushroom Market Size, Share & Trends Analysis Report By Product (Psilocybe, Gymnopilus, Panaeolus), By Form (Dried, Processed), By Application (De-addiction, Recreational), And Segment Forecasts, 2023 - 2030
... Trends The U.S. psychedelic mushroom market size is expected to reach USD 4,321.0 million by 2030, grow at a CAGR of 11.3% from 2023 to 2030 according to a new report by Grand View Research, ... Read More
-
Magnetoencephalography Market - By Product (Cryogenic/Conventional Systems, OPM Systems), By Application (Clinical, {Epilepsy, Autism, Dementia, Stroke, Traumatic brain injury}, Research), By End-use (Hospitals, Imaging Centers, Academic and Research Institutes) & Forecast, 2023 - 2032
... Market is anticipated to demonstrate growth during 2023–2032 owing to the constant technological innovations across magnetoencephalography that have improved the diagnosis of several neurological disorders, offered better clinical results, and increased the life expectancy among ... Read More
-
Vagus Nerve Stimulation Market By Product (Implantable VNS devices, External VNS devices), By Application (Epilepsy, Depression, Others), By End user (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... stimulation market size was valued at $488.5 million in 2022, and is projected to reach $836.1 million by 2032, growing at a CAGR of 5.5% from 2023 to 2032. Vagus nerve stimulation (VNS) is a ... Read More
-
Treatment-resistant Depression - Epidemiology Forecast - 2032
... Treatment Resistant Depression (TRD) epidemiology trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. Treatment Resistant Depression (TRD) Understanding Treatment Resistant Depression (TRD) Overview Treatment-resistant Depression (TRD) typically refers ... Read More
-
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... of OCD in 2023 in the 16 major markets. The marketed drugs space for OCD is made up of small molecules. Their modes of action are mainly gamma-aminobutyric acid type A receptor subunit agonists and ... Read More
-
Global Benzodiazepines Market Growth (Status and Outlook) 2023-2029
... region and market sector of projected Benzodiazepines sales for 2023 through 2029. With Benzodiazepines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ... Read More
-
Neurofeedback Market, by Product (Amplifiers, Electrodes or Sensors, and Computer Software), by System (Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), ... Read More
-
Global Depression-MDD Drugs Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Depression-MDD Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
Research Assistance
